Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 6.07B P/E - EPS this Y -9.80% Ern Qtrly Grth -
Income -986.6M Forward P/E 9.66 EPS next Y 9.50% 50D Avg Chg -
Sales 2.63B PEG 2.11 EPS past 5Y 16.30% 200D Avg Chg -4.00%
Dividend N/A Price/Book 1.09 EPS next 5Y 4.70% 52W High Chg -40.00%
Recommedations 2.30 Quick Ratio 0.80 Shares Outstanding 668.14M 52W Low Chg 25.00%
Insider Own 16.61% ROA 1.29% Shares Float 404.46M Beta 1.24
Inst Own 92.43% ROE -14.23% Shares Shorted/Prior 33.92M/38.48M Price 8.98
Gross Margin 65.52% Profit Margin -34.66% Avg. Volume 4,943,898 Target Price 8.39
Oper. Margin 13.87% Earnings Date May 7 Volume 5,750,901 Change -3.23%
About Clarivate Plc

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.

Clarivate Plc News
03/21/24 Clarivate Acquires AI Start Up to Accelerate Strategy and Business Development Success for Life Sciences & Healthcare Clients
03/20/24 New Webinar: Clarivate in the Age of AI - Driving Innovation in Intellectual Property Management and Decision Making
03/13/24 New Webinar: Clarivate in the Age of AI - Empowering Our Life Sciences & Healthcare Customers to Create a Healthier Tomorrow
03/07/24 Clarivate to Present at the BofA Securities 2024 Information & Business Services Conference on March 14
03/06/24 New Webinar: Clarivate in the Age of AI - Innovation Rooted in Academia
03/05/24 Clarivate Reveals Top 100 Global Innovators 2024
03/04/24 Clarivate and Exor Sign Agreement Under Which Suzanne Heywood Will Be Nominated to Stand for Election to the Company's Board of Directors
02/27/24 Clarivate Reports Fourth Quarter and Full Year 2023 Results
02/23/24 Clarivate Recognized in the WTR 1000 2024 for Trademark Business
02/20/24 Clarivate Launches New Center for Intellectual Property and Innovation Research
02/12/24 Clarivate Partners with the Financial Times to Power its Business School Rankings
02/01/24 Clarivate Completes Refinancing of Term Loan and Revolver Extension
01/29/24 Clarivate Launches Web of Science Grants Index to Help Researchers Optimize Funding Strategies
01/24/24 Clarivate to Report Fourth Quarter and Full Year 2023 Results on February 27, 2024
01/22/24 Clarivate Announces Commencement of Term Loan Refinancing Transaction
01/08/24 Clarivate Identifies Thirteen Potential Blockbuster Drugs and Gamechangers in Annual Drugs to Watch Report
12/19/23 Clarivate Reveals Stronger Outlook for Pulsed-field Ablation Market and Potential for Device to Revolutionize Treatment Paradigm
12/05/23 Clarivate Expands Partnership with VeriSIM Life to Accelerate and De-risk Research and Drug Development
11/15/23 Clarivate Reveals World's Influential Researchers in Highly Cited Researchers 2023 List
11/08/23 Clarivate to Present at the RBC Capital Markets 2023 Technology, Internet, Media and Telecommunications Conference on November 14, 2023
CLVT Chatroom

User Image Stock_Titan Posted - 1 week ago

$CLVT Clarivate Acquires AI Start Up to Accelerate Strategy and Business Development Success for Life Sciences & Healthcare Clients https://www.stocktitan.net/news/CLVT/clarivate-acquires-ai-start-up-to-accelerate-strategy-and-business-kx2rs6jtrwr0.html

User Image Stock_Titan Posted - 1 week ago

$CLVT New Webinar: Clarivate in the Age of AI - Driving Innovation in Intellectual Property Management and Decision Making https://www.stocktitan.net/news/CLVT/new-webinar-clarivate-in-the-age-of-ai-driving-innovation-in-swjkkknimx5q.html

User Image Sabre2222 Posted - 1 week ago

$CLVT WOOHOO was hoping for 10%+ but i'm happy with 8-9%

User Image Sabre2222 Posted - 1 week ago

$CLVT cmon buddy get up to $7.25 and I'm out with a nice profit.

User Image Stock_Titan Posted - 2 weeks ago

$CLVT New Webinar: Clarivate in the Age of AI - Empowering Our Life Sciences & Healthcare Customers to Create a Healthier Tomorrow https://www.stocktitan.net/news/CLVT/new-webinar-clarivate-in-the-age-of-ai-empowering-our-life-sciences-140g7aomrt4u.html

User Image Sabre2222 Posted - 2 weeks ago

$CLVT looks like i'll be here another week with the stimulating conversation that goes on here with the whopping 140 watchers :)

User Image Sabre2222 Posted - 2 weeks ago

$CLVT might have to settle for only 6% gain on this one. Taking to long.

User Image Stock_Titan Posted - 3 weeks ago

$CLVT Clarivate to Present at the BofA Securities 2024 Information & Business Services Conference on March 14 https://www.stocktitan.net/news/CLVT/clarivate-to-present-at-the-bof-a-securities-2024-information-amp-urwi59qpkzfi.html

User Image Stock_Titan Posted - 3 weeks ago

$CLVT New Webinar: Clarivate in the Age of AI - Innovation Rooted in Academia https://www.stocktitan.net/news/CLVT/new-webinar-clarivate-in-the-age-of-ai-innovation-rooted-in-z4kxk9vndn0y.html

User Image Ninja_Tradez Posted - 3 weeks ago

📢 $CLVT - Clarivate Plc (CLVT) Q4 2023 Earnings Call Transcript https://newsfilter.io/a/5570dbba7936baf8e955531c74212571

User Image tradestockforfun Posted - 02/29/24

$CLVT This is a good hold for long term. Real value is yet to show up. Short term easy $9 and above.

User Image Sabre2222 Posted - 02/29/24

$CLVT get up to $8

User Image Gumbomambo Posted - 4 weeks ago

$CLVT this price action 🙄

User Image Ninja_Tradez Posted - 4 weeks ago

📢 $CLVT - RBC Capital Maintains Sector Perform on Clarivate, Lowers Price Target to $8 https://newsfilter.io/a/84763e4b4eb8205efcf9dd497e578ef4

User Image tradingtwenty Posted - 1 month ago

Top 5 oversold stocks that have trended in the past 24 hours: $PRGO 21.95 🔥 $IRBT 24.19 $NERV 25.37 $CLVT 25.38 $GNL 28.49 Values range from 0 to 100, where 30 or below is oversold and 70 or above overbought. Link: https://tradingtwenty.com/dashboard/trending/past

User Image Sabre2222 Posted - 1 month ago

$CLVT lets run past $8 today

User Image Ninja_Tradez Posted - 1 month ago

📢 $CLVT - Oppenheimer Maintains Outperform on Clarivate, Lowers Price Target to $10 https://newsfilter.io/a/a27e290fe4c4137f1add4f571df50f72

User Image faucis_picks Posted - 1 month ago

$CLVT close $8+

User Image tradestockforfun Posted - 1 month ago

$CLVT Bull Flag all over now 😀🚀🚀🚀🚀

User Image tradestockforfun Posted - 1 month ago

$CLVT Easy hold ❤️🚀

User Image tradestockforfun Posted - 1 month ago

$CLVT I m in 🚀🚀🚀

User Image faucis_picks Posted - 1 month ago

$CLVT forward pe on this under 10 huge buy here

User Image kellysmith1 Posted - 1 month ago

$CLVT this makes no sense at all!!

User Image HereKittyKitty Posted - 1 month ago

$CLVT I’m in

User Image kellysmith1 Posted - 1 month ago

$CLVT Wow…

User Image faucis_picks Posted - 1 month ago

$CLVT wow

User Image TwoSunNick Posted - 1 month ago

$CLVT 👀

User Image Stocksrunner Posted - 1 month ago

📉 Today's Top Losers: $CLVT - Clarivate sees full-year results below street view, leading to a 5.7% drop in stock after reporting a Q4 revenue miss. $PRGO - Perrigo launches Project Energize to cut costs, with a 6% job cut, resulting in a significant decline. FY24 guidance also falls below estimates. $AJX - Great Ajax reports GAAP EPS of -$0.86 and reduces dividend by 9% to $0.10, contributing to a notable decrease in stock value. $CAN - Canaan reports Non-GAAP EPS of -$0.30, missing estimates, but beats revenue expectations, causing a decline in stock value. $IMXI - International Money Express reports Non-GAAP EPS of $0.56, beating expectations, but misses revenue estimates, resulting in a stock decrease. Stay informed and assess the market dynamics for potential opportunities.

User Image OpenOutcrier Posted - 1 month ago

$CLVT (-7.4% pre) Clarivate PLC (CLVT) Reports Mixed 2023 Financial Results and Provides 2024 Outlook https://ooc.bz/l/26187

User Image briefingcom Posted - 1 month ago

$CLVT: Clarivate beats by $0.02, reports revs in-line; guides FY24 EPS below consensus, revs below consensus https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240227061425CLVT&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

Analyst Ratings
Morgan Stanley Equal-Weight Feb 28, 24
Barclays Underweight Feb 28, 24
RBC Capital Sector Perform Feb 28, 24
Oppenheimer Outperform Feb 28, 24
Oppenheimer Outperform Jan 8, 24
Wells Fargo Underweight Dec 15, 23
Oppenheimer Outperform Oct 5, 23
Citigroup Neutral Sep 26, 23
Barclays Underweight Sep 8, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Samson James Gordon Chief Product Office.. Chief Product Officer May 16 Sell 14.2494 50,000 712,470 838,787 05/17/22
Samson James Gordon Chief Product Office.. Chief Product Officer May 11 Sell 13.91 58,000 806,780 888,787 05/13/22
Samson James Gordon Chief Product Office.. Chief Product Officer Mar 14 Sell 14.13 16,000 226,080 946,787 03/16/22